Hasil Pencarian - Chetan Dhamne

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times?

    Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times? oleh Megha Chetan Dhamne

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Sorafenib and Everolimus for paediatric patients with unresectable osteosarcoma

    Sorafenib and Everolimus for paediatric patients with unresectable osteosarcoma oleh Shilpa Vijayasrinivasan, Chetan Dhamne

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine

    Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine oleh Ashish Chavan, Bharati Shriyan, Preeti Chavan, Aditi Shirsat, Umakant Gavhane, Babu Pillai, Vivek Bhat, Chetan Dhamne, Vikram Gota

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Outcome of pediatric relapsed refractory Hodgkin lymphoma experience from Tata Memorial Hospital , Mumbai

    Outcome of pediatric relapsed refractory Hodgkin lymphoma experience from Tata Memorial Hospital , Mumbai oleh Ankita Pandey, Shyam Srinivasan, Nirmalya Moulik, Chetan Dhamne, Akanksha Chicchra, Sneha Shah, Tanuja Seth, Sumeet Gujral, S.D. Banavali, Gaurav Narula

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 decades

    Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 deca... oleh Nirmalya Roy Moulik, Ankita Pandey, Gaurav Chatterjee, Chetan Dhamne, Akanksha Chichra, Dhanlaxmy Shetty, Prashant Tembhare, Papagudi Subramanian, Nikhil Patkar, Gaurav Narula, Shripad Banavali

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)

    P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL) oleh Prashant Tembhare, Simpy Raj, Sitaram Ghogale, Nilesh Deshpande, Karishma Girase, Gaurav Chatterjee, Sweta Rajpal, Nikhil Patkar, Gaurav Narula, Bhausaheb Bagal, Hasmukh Jain, Manju Sengar, Shripad Banavali, Dhanlaxmi Shetty, Chetan Dhamne, Twinkle Khanka, Steffi Varghese, Shaista Jasdanwala, Navin Khattry, Papagudi G Subramanian, Sumeet Gujral

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid Malignancies

    Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid Malignancies oleh Sudivya Sharma, Chetan Dhamne, Shilpushp Bhosale, Badira Parambil, Jigeeshu Divatia, Girish Chinnaswamy, Vasundhara Patil, Rishikesh Joshi, Sridhar Epari, Anita Mahadevan, Sunil Vaidya, Shilpa Kulkarni, Atul Kulkarni, Vijaya Patil, Shyam Srinivasan, Venkata Rama Mohan Gollamudi, Nirmalya Roy Moulik, Maya Prasad, Gaurav Narula, Shripad Banavali

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: